Table 2.
Characteristics | CMV-positive infants n=39 n (%) | CMV-negative infants n=1039 n (%) | p-value |
---|---|---|---|
Sex | |||
Female | 22 (56·4) | 511 (49·2) | 0·375 |
Male | 17 (43·6) | 528 (50·8) | |
Mode of delivery | |||
Vaginal | 37 (94·9) | 990 (95·) | 0·707 |
C-section | 2 (5·1) | 49 (4·7) | |
Gestational age at birth | |||
<37 weeks | 10 (25·6) | 168 (16·2) | 0·118 |
≥37 weeks | 29 (74·4) | 871 (83·8) | |
Clinical characteristics at birth | |||
Small for gestational age* | 1 (2·6) | 16 (1·5) | 0·468 |
Petechiae | 0 | 11 (1·0) | – |
Purpura | 0 | 3 (0·3) | – |
Splenomegaly | 0 | 4 (0·4) | – |
Hepatomegaly | 0 | 3 (0·3) | – |
Jaundice | 0 | 6 (0·6) | – |
Seizures | 0 | 5 (0·5) | – |
Microcephaly | 0 | 0 | – |
Neurological abnormalities | 0 | 2 (0·2) | – |
Hospital visits during first 6 weeks of life | |||
No visits | 16 (41·0) | 354 (34·1) | 0·346 |
1 visit | 10 (25·6) | 385 (37·1) | |
≥2 visits | 13 (33·3) | 300 (28·9) |
Six twins were small for gestational age, including one CMV-discordant twin pair, one CMV-negative pair, and two other twins